- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04358978
A Novel Approach to Posterior Mesh Fixation in Laparoscopic Sacral Colpopexy
July 22, 2020 updated by: Maurizio Guido, Catholic University of the Sacred Heart
A Novel Approach to Posterior Mesh Fixation in Laparoscopic Sacral Colpopexy: a Randomized Control Trial
This randomized controlled study is designed to test the non inferiority of no attachment of posterior mesh compared to fixation of posterior mesh to the vagina in laparoscopic sacral colpopexy in terms of anatomical correction of the prolapse, post-operative and long term morbidity and rate of recurrence.
Study Overview
Status
Unknown
Conditions
Study Type
Interventional
Enrollment (Anticipated)
150
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Maurizio Guido
- Phone Number: 3393894243
- Email: maurizioguido@libero.it
Study Locations
-
-
Bari
-
Acquaviva delle Fonti, Bari, Italy, 70021
- Recruiting
- ospedale regionale Miulli
-
Contact:
- Maurizio Guido, PhD
- Phone Number: 3393894243
- Email: maurizioguido@libero.it
-
Principal Investigator:
- Maurizio Guido, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 73 years (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
-patients who required surgical treatment for symptomatic pelvic organ prolapse stage ≥ 2 with or without stress urinary incontinence
Exclusion Criteria:
- Age > 75 years
- Severe cardiovascular or respiratory disease
- Pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: posterior mesh no attachment
laparoscopic sacral colpopexy with no fixation of posterior mesh
|
pelvic organ prolapse correction with laparoscopic sacralcolpopexy with no attachement of posterior mesh
|
Active Comparator: posterior mesh attachment
laparoscopic sacral colpopexy with fixation of posterior mesh by suture
|
pelvic organ prolapse correction with laparoscopic sacralcolpopexy with the attachement of posterior mesh to vagina
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
correction of pelvic organ prolapse
Time Frame: 1 year
|
number of women with correction of prolapse mesured in S POP-Q stage during FU visit
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
rate of recurrence
Time Frame: 1 year
|
number of women with de novo anterior or posterior or central prolapse
|
1 year
|
long term outcomes
Time Frame: 1 year
|
number of women with nicturia, dysuria, obstructed defecation , urinary incontinence, pelvic pain
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 23, 2020
Primary Completion (Anticipated)
September 30, 2021
Study Completion (Anticipated)
September 30, 2021
Study Registration Dates
First Submitted
April 21, 2020
First Submitted That Met QC Criteria
April 21, 2020
First Posted (Actual)
April 24, 2020
Study Record Updates
Last Update Posted (Actual)
July 24, 2020
Last Update Submitted That Met QC Criteria
July 22, 2020
Last Verified
July 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Ospedale "F. Miulli"
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pelvic Organ Prolapse
-
University of CalgaryAlberta Health services; Cook Group IncorporatedCompletedAnterior Pelvic Organ ProlapseCanada
-
Coloplast A/SCompletedPelvic Organ Prolapse (POP)United States
-
University of British ColumbiaCompletedPelvic Organ Prolapse, Patient EducationCanada
-
University of MelbourneCompletedVaginal Hysterectomy | Pelvic Organ Prolapse Vaginal SurgeryAustralia
-
Unity Health TorontoUnknownVoiding Dysfunction After Pelvic Organ Prolapse SurgeryCanada
-
Nykøbing Falster County HospitalZealand University Hospital; University Hospital, Gentofte, Copenhagen; Copenhagen...UnknownBenign Hysterectomy | Postoperative Pelvic Organ Prolapse | Suspension
-
Mackay Medical CollegeRecruitingPelvic Organ Prolapse | Stage III and IV High Grade Pelvic Organ ProlapseTaiwan
-
Peking Union Medical College HospitalUnknown
-
Gaziosmanpasa Research and Education HospitalRecruitingPatients With Pelvic Organ Prolapse | Pectopexy | Lateral Suspension | Pop-q | Pisq-12Turkey
-
Charles University, Czech RepublicUnknownPelvic Organ Prolapse RecurrenceCzech Republic
Clinical Trials on laparoscopic sacral colpopexy with posterior mesh no attachment
-
Catholic University of the Sacred HeartMiulli General HospitalCompleted
-
Grubnik VolodymyrCompletedHiatal Hernia | Gastroesophageal Reflux Disease
-
Odessa National Medical UniversityUnknown